Factor Structure Underlying Components of Allostatic Load

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  McCaffery, Jeanne M ^a   Marsland, Anna L ^b   Strohacker, Kelley ^a   Muldoon, Matthew F ^b   Manuck, Stephen B ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGE; ALLOSTASIS; ARTICLE; ATTRIBUTABLE RISK; BODY MASS; CAUCASIAN; CONFOUNDING VARIABLE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ELECTROCARDIOGRAPHY; FACTORIAL ANALYSIS; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX RATIO; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VAGUS TONE; WAIST CIRCUMFERENCE;

ADULT; AFRICAN AMERICANS; ALLOSTASIS; ANALYSIS OF VARIANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL;

EID: 84868091986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047246     Document Type: Article

References (58)

1. Haffner SM, (2000) Obesity and the metabolic syndrome: the San Antonio Heart Study. Br J Nutr 83 (Suppl 1): S67-70.
2. Reaven GM, (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
3. Timar O, Sestier F, Levy E, (2000) Metabolic syndrome X: a review. Can J Cardiol 16: 779-789.
4. Haffner SM, Ferrannini E, Hazuda HP, Stern MP, (1992) Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 20: 38-45.
5. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB, (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159: 1104-1109.
6. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, et al. (1996) Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 45: 699-706.
7. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K, (2000) Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20: 538-544.
8. Lindblad U, Langer RD, Wingard DL, Thomas RG, Barrett-Connor EL, (2001) Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 153: 481-489.
9. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, et al. (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 14: 1940-1945.
10. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J, (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100: 123-128.
11. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.
12. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, et al. (2011) A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes 60: 2417-2423.
13. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, et al. (2012) Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 8: e1002607.
14. Hung J, McQuillan BM, Thompson PL, Beilby JP, (2008) Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond) 32: 772-779.
15. Kristiansson K, Perola M, Tikkanen E, Kettunen J, Surakka I, et al. (2012) Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet 5: 242-249.
16. Leu HB, Chung CM, Lin SJ, Jong YS, Pan WH, et al. (2011) Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 6: e19999.
17. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477: 54-60.
18. McEwen BS, Stellar E, (1993) Stress and the individual. Mechanisms leading to disease. Arch Intern Med 153: 2093-2101.
19. Seeman T, Epel E, Gruenewald T, Karlamangla A, McEwen BS, (2010) Socio-economic differentials in peripheral biology: cumulative allostatic load. Ann N Y Acad Sci 1186: 223-239.
20. Seeman TE, McEwen BS, Rowe JW, Singer BH, (2001) Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A 98: 4770-4775.
21. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS, (1997) Price of adaptation-allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med 157: 2259-2268.
22. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE, (2002) Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol 55: 696-710.
23. Goldman N, Turra CM, Glei DA, Seplaki CL, Lin YH, et al. (2006) Predicting mortality from clinical and nonclinical biomarkers. J Gerontol A Biol Sci Med Sci 61: 1070-1074.
24. Bentler PM, Weeks DG, (1980) Linear structural equations with latent variables. Psychometrika 45: 289-308.
25. Bentler PM (1995) EQS structural equations program manual. Encino, CA: Multivariate Software.
26. Lawlor DA, Ebrahim S, May M, Davey Smith G, (2004) (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 159: 1013-1018.
27. Novak S, Stapleton LM, Litaker JR, Lawson KA, (2003) A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diabetes Obes Metab 5: 388-396.
28. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, et al. (2006) A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29: 113-122.
29. Shen BJ, Goldberg RB, Llabre MM, Schneiderman N, (2006) Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol 16: 131-137.
30. Shen BJ, Todaro J, Niaura R, McCaffery JM, Zhang J, et al. (2003) Are metabolic risk factors one united syndrome- modeling of the structure of the metabolic syndrome X. Am J Epidemiol. 157: 701-711.
31. Marsland AL, McCaffery JM, Muldoon MF, Manuck SB, (2010) Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 59: 1801-1808.
32. McCaffery JM, Shen BJ, Muldoon MF, Manuck SB, (2007) Ambulatory blood pressure and the metabolic syndrome in normotensive and untreated hypertensive men. Metab Syndr Relat Disord 5: 34-44.
33. Bleil ME, Gianaros PJ, Jennings JR, Flory JD, Manuck SB, (2008) Trait negative affect: toward an integrated model of understanding psychological risk for impairment in cardiac autonomic function. Psychosom Med 70: 328-337.
34. Halder I, Marsland AL, Cheong J, Muldoon MF, Ferrell RE, et al. (2010) Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun 24: 160-167.
35. Manuck SB, Craig AE, Flory JD, Halder I, Ferrell RE, (2011) Reported early family environment covaries with menarcheal age as a function of polymorphic variation in estrogen receptor-alpha. Dev Psychopathol 23: 69-83.
36. Manuck SB, Phillips JE, Gianaros PJ, Flory JD, Muldoon MF, (2010) Subjective socioeconomic status and presence of the metabolic syndrome in midlife community volunteers. Psychosom Med 72: 35-45.
37. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065.
38. Weber EJM, Molenaar PCM, van der Molen MW, Mulder LJM, Maarse FJ, et al. (1991) PSPAT: A program for spectral analysis of point events including a test for stationarity. Computers in Psychology: Applications in Education, Research, and Psychodiagnostics. Amsterdam: Swets & Zeitlinger. 132-139.
39. Pyetan E, Akselrod S, (2003) Do the high-frequency indexes of HRV provide a faithful assessment of cardiac vagal tone? A critical theoretical evaluation. IEEE Trans Biomed Eng 50: 777-783.
40. Bentler PM, (1990) Comparative fit indexes in structural models. Psychol Bull 107: 238-246.
41. McDonald RP, Marsh HW, (1990) Choosing a multivariate model: Noncentrality and goodness of fit. Psychological Bulletin 107: 247-255.
42. Llabre MM, Fitzpatrick SL, (2012) Revisiting measurement models in psychosomatic medicine research: a latent variable approach. Psychosom Med 74: 169-177.
43. Juster RP, McEwen BS, Lupien SJ, (2010) Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 35: 2-16.
44. Reilly MP, Rader DJ, (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108: 1546-1551.
45. Tracey KJ, (2002) The inflammatory reflex. Nature 420: 853-859.
46. Tracey KJ, (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117: 289-296.
47. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
48. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
49. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, et al. (2004) Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25: 363-370.
50. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, et al. (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13: 178-184.
51. Thayer JF, Fischer JE, (2009) Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 265: 439-447.
52. Janszky I, Ericson M, Lekander M, Blom M, Buhlin K, et al. (2004) Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 256: 421-428.
53. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
54. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, et al. (2010) Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59: 1266-1275.
55. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
56. Eijgelsheim M, Newton-Cheh C, Sotoodehnia N, de Bakker PI, Muller M, et al. (2010) Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet 19: 3885-3894.
57. Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, et al. (2009) Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 5: e1000338.
58. Lemaitre RN, Tanaka T, Tang W, Manichaikul A, Foy M, et al. (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7: e1002193.